Ziad Anwar Ali MD DPhil
Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Cardiothoracic Imaging
Director of the DeMatteis Cardiovascular Institute, St Francis Hospital & Heart Center
St Francis Hospital & Heart Center100 Port Washington BlvdRoslyn, NY 11576
Fax+1 516-562-6716
Overview of Dr. Ali
Dr. Ziad Ali is a cardiologist in Roslyn, NY and is affiliated with multiple hospitals in the area, including St. Francis Hospital and Heart Center, New York-Presbyterian Hospital, The Mount Sinai Hospital, NewYork-Presbyterian/Lawrence Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Sheffield School of Medicine and has been in practice 17 years. He is one of 695 doctors at New York-Presbyterian Hospital and one of 603 doctors at The Mount Sinai Hospital who specialize in Cardiology. He has more than 100 publications and over 500 citings.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Interventional Cardiology, 2011 - 2012
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2009 - 2011- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2007 - 2009
Stanford Health CarePost-Doctoral Fellowship, 2006 - 2007
University of Sheffield School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2009 - 2026
NY State Medical License 2011 - 2026
TX State Medical License 2020 - 2026
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- Rationale and design of the prevail global trial program evaluating the prevail drug-coated balloon in patients with in-stent restenosis and de novo small vessel disease.David E Kandzari, Azeem Latib, Darren Mylotte, Ziad A Ali, Azfar Zaman
American Heart Journal. 2025-05-01 - 1 citationsOrbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a...Ajay J Kirtane, Philippe Généreux, Bruce Lewis, Richard A Shlofmitz, Suhail Dohad
Lancet. 2025-04-12 - Evidence of Benefit for Chronic Total Occlusion Revascularization From ISCHEMIA: New Road or Dead End?Ziad A Ali, Rasha Al-Lamee, John A Bittl
Journal of the American College of Cardiology. 2025-04-01
Lectures
- Treating Patients With Renal Insufficiency: Zero Contrast PCICRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- Precision PCI: Use of Intravascular Imaging and Physiology to Optimize Results2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- The Calcium Conundrum: Best Strategies to Recognize and Deal With Severely Calcified Lesions2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Join now to see all
Press Mentions
ISCHEMIA: No Clinical Event Reduction with Invasive Strategy in CTO PatientsMarch 26th, 2025- Medtronic Enrolls First Patient in New Coronary DCB Trial—Data Could Lead to FDA ApprovalFebruary 26th, 2025
- Medtronic Enrolls First Patient in Drug-Coated Balloon StudyFebruary 26th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
